The global Glycomics market gathered revenue around USD 1.9 billion in 2021 and market is set to grow USD 4.1 billion by the end of 2030 and is estimated to expand at a modest CAGR of 12.9% during the prediction period 2022 to 2030.
The increasing demand for treatments for various chronic diseases is fueling the growth of the global glycomics market. Pharmaceutical companies are paving their ways in the global market to support R&D activities in glycans to generate more revenue opportunities. Increasing government expenditure on healthcare as well as in research & development activities in bioinformatics strengthen the scope and expansion of the market. Since cancer is one of the leading causes of death, there is an increasing focus of market contributors to support drug discovery and development activities in the field of oncology to create profitable opportunities.
Report Scope of the Glycomics Market
Glycomics Market: Overview
- This report analyzes the current scenario and future prospects of the global glycomics market. Growth of the global glycomics market is driven by increase in research activities on glycomics and rise in R&D investments in pharmaceutical and biotechnology companies.
- The report provides an elaborate executive summary, including a snapshot of various segments of the global glycomics market. It also provides elaborate information and data analysis of the global glycomics market with regard to segments based on product type, application, end-user, and region.
- The overview section of the report provides a detailed qualitative analysis of the drivers and restraints, and opportunities that affect the global glycomics market
- Additionally, the report includes company profiles, which provide information about their business, product portfolios, and competition landscape in the glycomics market
- The report on the global glycomics market offers market attractiveness analysis of the regions and segments
- The last section of the report comprises quantitative and qualitative analysis on market share/position of key players operating in the global glycomics market. It analyzes the key competitive strategies adopted by the major industry players, thereby presenting a thorough understanding of the competitive scenario in the global glycomics market.
Government Initiatives to Support and Invest in R&D Activities
Glycomics is the study of structure, biology, and function of saccharides or glycans, which can be found in all living organisms. The application of glycobiology in drug discovery & development, disease diagnostics, oncology, immunology, etc. has created tremendous growth opportunities for the players operating in the global market. The global glycomics market is expected to expand at a CAGR of 12.9% during the forecast period of 2022-2030. Pharmaceutical companies are increasing their output capacities to support the global glycomics market. Governments are taking steps ahead to support manufacturers in the pharmaceutical companies, and investing in R&D activities. The increasing healthcare expenditure by governments of developing countries to support research activities in the global market help fuel market growth.
Expansion of Academic & Research Institutes to Support Market Growth
Growth and advancement academic & research institutes to study glycomics, which has many applications in rapid development of drugs, vaccine development, and precision medicines, are factors expected to drive the global market during the forecast period. Increasing collaborations between research institutions and key market contributors to support research activities in biomedical and biochemistry are responsible for generating revenue streams. Expanding contact research organizations in pharmaceuticals to outsource R&D activities to stay ahead of the competition help grow manufactures operating in the global glycomics market. Increasing collaborate activities of market players and research institutes to study proteomics and glycomics to discover solutions on genetic diseases drives the global glycomics market.
Glycomics Market: Key Segments
- In terms of product type, the global glycomics market has been classified into enzymes, instruments, kits, and reagents. The enzymes segment accounted for major share of the global glycomics market in 2020, and the trend is anticipated to continue during the forecast period.
- Based on application, the global glycomics market has been categorized into diagnostics, drug discovery & development, oncology immunology, and others
- In terms of end-user, the global glycomics market has been divided into academic research institutes, pharmaceutical & biotechnology companies, and contract research organizations
- The market value and forecast for each of these segments have been provided from 2017 to 2030. The CAGR of respective segments has also been provided from 2022 to 2030, considering 2017 to 2019 as the historical years and 2021 as the base year.
Glycomics Market: Regional Outlook
- The global glycomics market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.
- The glycomics market report provides value and forecast for each region and country/sub-region from 2017 to 2030. The compound annual growth rates (CAGRs) for each of these regions and countries have also been provided for the forecast period from 2022 to 2030. The glycomics market study also covers the competitive scenario in these regions.
Some of the prominent players in the Glycomics Market include:
- Agilent Technologies, Inc.
- Asparia Glycomics
- Bruker Corporation
- Canadian Glycomics Network (GLYCONET)
- Glyco Expression Technologies, Inc.
- Glycodiag
- Merck KGaA
- New England Biolabs
- RayBiotech, Inc.
- Shimadzu Corporation
- Thermo Fisher Scientific Inc.
- Vector Laboratories
- Glyde Bio, Inc.
Segments Covered in the Report
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:
- By Product Type
- Enzymes
- Glycosidases
- Glycosyltransferases
- Neuraminidases
- Sialyltransferases
- Others
- Instruments
- Antibody Arrays
- HPLC
- Lectin Arrays
- MALDI-TOF
- Other Glycomics Instruments
- Kits
- Glycan Labeling Kits
- Glycan Purification Kits
- Glycan Release Kits
- Others
- Reagents
- Glycoproteins
- Monosaccharides
- Oligosaccharides
- Others
- By Application
- Diagnostics
- Drug Discovery & Development
- Oncology
- Immunology
- Others
- By End User
- Academic Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
By Geography
North America
Europe
- Germany
- France
- United Kingdom
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of Middle East & Africa
Key Points Covered in Glycomics Market Study:
- Growth of Glycomics in 2022
- Market Estimates and Forecasts (2017-2030)
- Brand Share and Market Share Analysis
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Recommendation on Key Winning Strategies
- COVID-19 Impact on Demand for Glycomics and How to Navigate
- Key Product Innovations and Regulatory Climate
- Glycomics Consumption Analysis
- Glycomics Production Analysis
- Glycomics and Management
Request Customization
Get a Sample
Get a Sample
Request Customization